Natural Killer Cells Fail to Establish Stable Contacts with Cancer Cells and Show Impaired Control of Tumor Metastasis
Overview
Authors
Affiliations
CD226 is an activating receptor expressed on natural killer (NK) cells, CD8 T cells, and other immune cells. Upon binding to its ligands expressed on target cells, CD226 activates intracellular signaling that triggers cytokine production and degranulation in NK cells. However, the role of CD226 in contact dynamics between NK and cancer cells has remained unclear. Our time-lapse images showed that individual wild-type CD226 NK cells contacted B16F10 melanoma cells for 23.7 min, but NK cells only for 12.8 min, although both NK cell subsets showed equal contact frequency over 4 h. On the surface of B16F10 cells, CD226 cells stayed at the same site with oscillating movement (named stable contact), while NK cells moved around at a velocity of 4 μm/min (named unstable contact). Consequently, NK cells did not kill B16F10 cells and did not inhibit their metastasis into the lung . Taken together, our data demonstrate that CD226 enables prolonged stable interaction between NK and cancer cells, which is needed for efficient killing of cancer cells.
Carreira-Santos S, Lopez-Sejas N, Gonzalez-Sanchez M, Sanchez-Hernandez E, Pera A, Hassouneh F Front Immunol. 2023; 14:1256404.
PMID: 37908353 PMC: 10613704. DOI: 10.3389/fimmu.2023.1256404.
Franzese O, Graziani G Cancers (Basel). 2022; 14(22).
PMID: 36428727 PMC: 9688455. DOI: 10.3390/cancers14225633.
Functional visualization of NK cell-mediated killing of metastatic single tumor cells.
Ichise H, Tsukamoto S, Hirashima T, Konishi Y, Oki C, Tsukiji S Elife. 2022; 11.
PMID: 35113018 PMC: 8849286. DOI: 10.7554/eLife.76269.
Park E, Won Jun H, Ho Na I, Lee H, Yun J, Kim H Arch Pharm Res. 2021; 45(1):1-10.
PMID: 34905179 DOI: 10.1007/s12272-021-01365-z.
Targeting novel inhibitory receptors in cancer immunotherapy.
Ding Q, Chauvin J, Zarour H Semin Immunol. 2020; 49:101436.
PMID: 33288379 PMC: 8045408. DOI: 10.1016/j.smim.2020.101436.